Pieris Pharmaceuticals GmbH
Records under this name other than the patents Pieris Pharmaceuticals GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Back to Pieris Pharmaceuticals GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,064,963 | Methods and Compositions for Treating Disorders Lapsed on the fee record Ended Sep 4, 2026 · High confidence | Lapsed on the fee record | Ended Sep 4, 2026 | High confidence |
| US 10,046,027 | Muteins of Tear Lipocalin and Methods for Obtaining the Same Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 11,382,951 | Methods for Preventing or Treating Certain Disorders by Inhibiting Binding of IL-4 And/Or IL-13 to Their Respective Receptors Lapsed on the fee record Ended Jul 12, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 12, 2026 | Medium confidence |
| US 11,382,963 | Engineered T Cells and Uses Therefor Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 10,016,483 | Methods for Preventing or Treating Certain Disorders by Inhibiting Binding of IL-4 And/Or IL-13 to Their Respective Receptors Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |
| US 11,345,728 | Novel Specific-Binding Polypeptides and Uses Thereof Lapsed on the fee record Ended May 31, 2026 · Medium confidence | Lapsed on the fee record | Ended May 31, 2026 | Medium confidence |
| US 7,585,940 | Muteins of Human Tear Lipocalin Term ended Term ended Feb 4, 2026 · High confidence | Term ended | Term ended Feb 4, 2026 | High confidence |
| US 11,168,119 | Lipocalin Muteins with Binding Affinity for LAG-3 Lapsed on the fee record Ended Nov 9, 2025 · High confidence | Lapsed on the fee record | Ended Nov 9, 2025 | High confidence |
| US 9,751,920 | Muteins with Tear Lipocalin Having Affinity to Human C-Met Receptor Tyrosine Kinase and Methods for Obtaining the Same Lapsed on the fee record Ended Sep 5, 2025 · High confidence | Lapsed on the fee record | Ended Sep 5, 2025 | High confidence |
| US 7,691,970 | Muteins of a bilin-binding protein with affinity for a given target Term ended Term ended Jul 10, 2025 · USPTO record | Term ended | Term ended Jul 10, 2025 | USPTO record |